Feb 23, 2021
Aridis Pharmaceuticals Provides Multiple Program Updates Including the Addition of a Second Inhaled Antibody to Neutralize Newly Emerging COVID-19 Mutated Variants
Nov 24, 2020
Aridis Pharmaceuticals to Host Fireside Chat with Analysts to Discuss 2021 Outlook for its Lead Programs and Novel mAb Discovery Platform on December 4th, 2020
Nov 20, 2020
Aridis Pharmaceuticals Announces Third Quarter 2020 Results
Oct 27, 2020
Aridis Pharmaceuticals to Present at the ROTH Capital Partners 2020 MedTech Innovation Forum on a COVID-19 Panel
Oct 14, 2020
Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering
Sep 08, 2020
Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501
Sep 04, 2020
Aridis Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 11, 2020
Aridis Pharmaceuticals Announces Second Quarter 2020 Results
Jun 26, 2020
Aridis Pharmaceuticals to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
Jun 18, 2020
Aridis Pharmaceuticals to Discuss APEX(TM) in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
Jun 15, 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
May 12, 2020
Aridis Pharmaceuticals Announces First Quarter 2020 Results
May 04, 2020
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)
Apr 29, 2020
Aridis Pharmaceuticals to Participate in Maxim Group's Infectious Disease Virtual Conference
Mar 06, 2020
Aridis Pharmaceuticals to Postpone Investor Day Due to Coronavirus Concerns
Mar 05, 2020
Aridis Pharmaceuticals to Present at the 32nd Annual ROTH Conference
Mar 04, 2020
Aridis Pharmaceuticals Provides Update on Investor Day Featuring Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
Feb 18, 2020
Aridis Pharmaceuticals to Host Investor Day Showcasing APEX(TM) Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
Jan 28, 2020
Aridis Pharmaceuticals Presents APEX(TM) Antibody Discovery and Production Platform Technology at the 19th Annual CHI PepTalk Conference
Jan 02, 2020
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer